$DJI 0.14% NDX 0.31% SPX 0.07% VIX 3.38% News 1
Mon, Sep 16 4:20am

UTHR $80.69 0.87 (1.09%)
United Therapeutics Corp

UTHR Profile

Market Cap 3.50 Billion
UTHR Description

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for pulmonary arterial hypertension largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Nearly all of its sales are generated within the United States. United also markets a pediatric oncology drug, but its focus largely remains in pulmonary hypertension.

Visit Website

UTHR Earnings

EPS 4.68 P/E Ratio 9.22
Previous Wed, May 1, 2019
Latest Wed, Jul 31, 2019 (47 days ago) +1.46%

UTHR Dividend

Yield --
Ex-Date --
Pay Date --
History --

UTHR Charts

1 Year
Jul 22, 2019
Oct 3, 2018

Symbol Price Day Δ YTD Δ
UTHR $80.69 1.09% -25.04%


Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy